Chargement en cours...
Should we stop prescribing metoclopramide as a prokinetic drug in critically ill patients?
Regulatory agencies in North America and Europe recently re-evaluated the safety of metoclopramide. This re-evaluation resulted in recommendations and restrictions in order to minimise the risk of neurological and other adverse reactions associated with the use of metoclopramide. In the ICU, off-lab...
Enregistré dans:
| Publié dans: | Crit Care |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4331179/ https://ncbi.nlm.nih.gov/pubmed/25672546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-014-0502-4 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|